Indeed, severe atopic disease observed in patients carrying CARD11 loss-of-function mutations can be attributed to defects in both NF-κB and mTORC1 activation in T cells (79), although none of these patients have presented with significant EBV infections. Here, NFKB1 is linked to Epstein-Barr virus infection.